Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2637.0
(0.65%)
JPY 2637.0
(0.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 430.65 Billion JPY | 15.97% |
| 2022 | 371.34 Billion JPY | 12.55% |
| 2021 | 329.93 Billion JPY | 34.3% |
| 2020 | 245.66 Billion JPY | 7.68% |
| 2019 | 228.13 Billion JPY | 20.83% |
| 2018 | 188.8 Billion JPY | 6.47% |
| 2017 | 177.32 Billion JPY | 7.31% |
| 2016 | 165.24 Billion JPY | 5.35% |
| 2015 | 156.85 Billion JPY | 29.43% |
| 2014 | 121.18 Billion JPY | 17.3% |
| 2013 | 103.31 Billion JPY | 15.18% |
| 2012 | 89.7 Billion JPY | 10.41% |
| 2011 | 81.24 Billion JPY | 11.35% |
| 2010 | 72.96 Billion JPY | 20.59% |
| 2009 | 60.5 Billion JPY | 25.43% |
| 2008 | 48.23 Billion JPY | 7.04% |
| 2007 | 45.06 Billion JPY | 3.2% |
| 2006 | 43.66 Billion JPY | 8.83% |
| 2005 | 40.12 Billion JPY | 4.31% |
| 2004 | 38.46 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 451.22 Billion JPY | 4.78% |
| 2023 Q4 | 430.65 Billion JPY | 3.85% |
| 2023 Q3 | 414.68 Billion JPY | 5.54% |
| 2023 FY | 430.65 Billion JPY | 15.97% |
| 2023 Q2 | 392.91 Billion JPY | -0.32% |
| 2023 Q1 | 394.17 Billion JPY | 6.15% |
| 2022 Q2 | 351.65 Billion JPY | 7.18% |
| 2022 Q3 | 357.31 Billion JPY | 1.61% |
| 2022 Q4 | 371.34 Billion JPY | 3.93% |
| 2022 FY | 371.34 Billion JPY | 12.55% |
| 2022 Q1 | 328.11 Billion JPY | -0.55% |
| 2021 Q2 | 252.9 Billion JPY | 1.49% |
| 2021 Q1 | 249.18 Billion JPY | 1.43% |
| 2021 FY | 329.93 Billion JPY | 34.3% |
| 2021 Q4 | 329.93 Billion JPY | 28.86% |
| 2021 Q3 | 256.03 Billion JPY | 1.24% |
| 2020 FY | 245.66 Billion JPY | 7.68% |
| 2020 Q1 | 245.14 Billion JPY | 7.45% |
| 2020 Q2 | 237.4 Billion JPY | -3.16% |
| 2020 Q3 | 237.67 Billion JPY | 0.11% |
| 2020 Q4 | 245.66 Billion JPY | 3.36% |
| 2019 FY | 228.13 Billion JPY | 20.83% |
| 2019 Q4 | 228.13 Billion JPY | 17.95% |
| 2019 Q3 | 193.42 Billion JPY | 0.58% |
| 2019 Q2 | 192.3 Billion JPY | 1.82% |
| 2019 Q1 | 188.86 Billion JPY | 0.03% |
| 2018 Q3 | 179.66 Billion JPY | 2.05% |
| 2018 Q4 | 188.8 Billion JPY | 5.09% |
| 2018 FY | 188.8 Billion JPY | 6.47% |
| 2018 Q1 | 174.19 Billion JPY | -1.77% |
| 2018 Q2 | 176.04 Billion JPY | 1.06% |
| 2017 Q1 | 166.53 Billion JPY | 0.78% |
| 2017 FY | 177.32 Billion JPY | 7.31% |
| 2017 Q4 | 177.32 Billion JPY | 0.04% |
| 2017 Q3 | 177.25 Billion JPY | 3.56% |
| 2017 Q2 | 171.15 Billion JPY | 2.77% |
| 2016 Q3 | 165.02 Billion JPY | 1.53% |
| 2016 FY | 165.24 Billion JPY | 5.35% |
| 2016 Q1 | 155.14 Billion JPY | -1.09% |
| 2016 Q4 | 165.24 Billion JPY | 0.13% |
| 2016 Q2 | 162.54 Billion JPY | 4.77% |
| 2015 Q1 | 129.64 Billion JPY | 6.98% |
| 2015 Q2 | 144.19 Billion JPY | 11.23% |
| 2015 Q3 | 146.52 Billion JPY | 1.61% |
| 2015 Q4 | 156.85 Billion JPY | 7.05% |
| 2015 FY | 156.85 Billion JPY | 29.43% |
| 2014 Q4 | 121.18 Billion JPY | 4.9% |
| 2014 Q3 | 115.52 Billion JPY | 9.52% |
| 2014 Q2 | 105.48 Billion JPY | 4.49% |
| 2014 FY | 121.18 Billion JPY | 17.3% |
| 2014 Q1 | 100.95 Billion JPY | -2.29% |
| 2013 Q2 | 88.35 Billion JPY | -0.07% |
| 2013 FY | 103.31 Billion JPY | 15.18% |
| 2013 Q3 | 97.63 Billion JPY | 10.49% |
| 2013 Q4 | 103.31 Billion JPY | 5.82% |
| 2013 Q1 | 88.41 Billion JPY | -1.43% |
| 2012 FY | 89.7 Billion JPY | 10.41% |
| 2012 Q4 | 89.7 Billion JPY | 4.28% |
| 2012 Q3 | 86.02 Billion JPY | -0.19% |
| 2012 Q2 | 86.18 Billion JPY | 0.66% |
| 2012 Q1 | 85.61 Billion JPY | 5.38% |
| 2011 FY | 81.24 Billion JPY | 11.35% |
| 2011 Q2 | 76.07 Billion JPY | 2.74% |
| 2011 Q3 | 79.17 Billion JPY | 4.08% |
| 2011 Q1 | 74.04 Billion JPY | 1.48% |
| 2011 Q4 | 81.24 Billion JPY | 2.61% |
| 2010 Q1 | 58.93 Billion JPY | -2.59% |
| 2010 Q4 | 72.96 Billion JPY | 4.56% |
| 2010 FY | 72.96 Billion JPY | 20.59% |
| 2010 Q2 | 65.31 Billion JPY | 10.83% |
| 2010 Q3 | 69.77 Billion JPY | 6.83% |
| 2009 FY | 60.5 Billion JPY | 25.43% |
| 2009 Q2 | 53.42 Billion JPY | 11.76% |
| 2009 Q3 | 55.2 Billion JPY | 3.34% |
| 2009 Q4 | 60.5 Billion JPY | 9.6% |
| 2009 Q1 | 47.8 Billion JPY | -0.91% |
| 2008 Q4 | 48.23 Billion JPY | 6.08% |
| 2008 FY | 48.23 Billion JPY | 7.04% |
| 2008 Q3 | 45.47 Billion JPY | 0.0% |
| 2007 FY | 45.06 Billion JPY | 3.2% |
| 2006 FY | 43.66 Billion JPY | 8.83% |
| 2005 FY | 40.12 Billion JPY | 4.31% |
| 2004 FY | 38.46 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -1077.516% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 97.15% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 52.545% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 69.606% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -2692.63% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | -63.495% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -150.93% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 69.102% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -2406.274% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | -30.986% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -171.192% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -463.24% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -769.163% |
| Tsumura & Co. | 428.25 Billion JPY | -0.56% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | -65.046% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -222.751% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -404.679% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -186.084% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -142.377% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -2762.242% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -454.194% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -2705.183% |
| MedRx Co., Ltd | 2.05 Billion JPY | -20886.988% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -2172.776% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -16788.353% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -21157.105% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -361.519% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | -12.729% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -10117.616% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 44.319% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -1245.622% |